BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22954747)

  • 1. Trypanosoma cruzi carrying a monoallelic deletion of the calreticulin (TcCRT) gene are susceptible to complement mediated killing and defective in their metacyclogenesis.
    Sánchez Valdéz FJ; Pérez Brandán C; Zago MP; Labriola C; Ferreira A; Basombrío MÁ
    Mol Immunol; 2013 Mar; 53(3):198-205. PubMed ID: 22954747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoallelic deletion of the TcCRT gene increases the attenuation of a cultured Trypanosoma cruzi strain, protecting against an in vivo virulent challenge.
    Sánchez-Valdéz FJ; Pérez Brandán C; Ramírez G; Uncos AD; Zago MP; Cimino RO; Cardozo RM; Marco JD; Ferreira A; Basombrío MÁ
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2696. PubMed ID: 24551259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin.
    Valck C; Ramírez G; López N; Ribeiro CH; Maldonado I; Sánchez G; Ferreira VP; Schwaeble W; Ferreira A
    Mol Immunol; 2010 Apr; 47(7-8):1516-21. PubMed ID: 20153898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity.
    Ramírez G; Valck C; Molina MC; Ribeiro CH; López N; Sánchez G; Ferreira VP; Billetta R; Aguilar L; Maldonado I; Cattán P; Schwaeble W; Ferreira A
    Immunobiology; 2011; 216(1-2):265-73. PubMed ID: 20472323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted deletion of the gp72 gene decreases the infectivity of Trypanosoma cruzi for mice and insect vectors.
    Basombrío MA; Gómez L; Padilla AM; Ciaccio M; Nozaki T; Cross GA
    J Parasitol; 2002 Jun; 88(3):489-93. PubMed ID: 12099416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi Calreticulin Topographical Variations in Parasites Infecting Murine Macrophages.
    González A; Valck C; Sánchez G; Härtel S; Mansilla J; Ramírez G; Fernández MS; Arias JL; Galanti N; Ferreira A
    Am J Trop Med Hyg; 2015 May; 92(5):887-97. PubMed ID: 25758653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous Calreticulin, incorporated onto non-infective Trypanosoma cruzi epimastigotes, promotes their internalization into mammal host cells.
    Sosoniuk-Roche E; Vallejos G; Aguilar-Guzmán L; Pizarro-Bäuerle J; Weinberger K; Rosas C; Valck C; Michalak M; Ferreira A
    Immunobiology; 2017 Mar; 222(3):529-535. PubMed ID: 27839837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable numbers of calreticulin genes in Trypanosoma cruzi correlate with atypical morphology and protein expression.
    González A; Härtel S; Mansilla J; Sánchez-Valdéz F; Ferreira A
    Immunobiology; 2018 Dec; 223(12):802-806. PubMed ID: 30131175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi calreticulin inhibits the complement lectin pathway activation by direct interaction with L-Ficolin.
    Sosoniuk E; Vallejos G; Kenawy H; Gaboriaud C; Thielens N; Fujita T; Schwaeble W; Ferreira A; Valck C
    Mol Immunol; 2014 Jul; 60(1):80-5. PubMed ID: 24769495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi.
    Cestari Idos S; Krarup A; Sim RB; Inal JM; Ramirez MI
    Mol Immunol; 2009 Dec; 47(2-3):426-37. PubMed ID: 19783051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi.
    Ferreira V; Valck C; Sánchez G; Gingras A; Tzima S; Molina MC; Sim R; Schwaeble W; Ferreira A
    J Immunol; 2004 Mar; 172(5):3042-50. PubMed ID: 14978109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vivo role for Trypanosoma cruzi calreticulin in antiangiogenesis.
    Molina MC; Ferreira V; Valck C; Aguilar L; Orellana J; Rojas A; Ramirez G; Billetta R; Schwaeble W; Lemus D; Ferreira A
    Mol Biochem Parasitol; 2005 Apr; 140(2):133-40. PubMed ID: 15760653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular growth and metacyclogenesis defects in Trypanosoma cruzi carrying a targeted deletion of a Tc52 protein-encoding allele.
    Allaoui A; François C; Zemzoumi K; Guilvard E; Ouaissi A
    Mol Microbiol; 1999 Jun; 32(6):1273-86. PubMed ID: 10383767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of classical complement component C1 with parasite and host calreticulin mediates Trypanosoma cruzi infection of human placenta.
    Castillo C; Ramírez G; Valck C; Aguilar L; Maldonado I; Rosas C; Galanti N; Kemmerling U; Ferreira A
    PLoS Negl Trop Dis; 2013; 7(8):e2376. PubMed ID: 23991234
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Ramírez-Toloza G; Ferreira A
    Front Microbiol; 2017; 8():1667. PubMed ID: 28919885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Trypanosoma cruzi calreticulin in the host-parasite interplay.
    Ramírez G; Valck C; Ferreira VP; López N; Ferreira A
    Trends Parasitol; 2011 Mar; 27(3):115-22. PubMed ID: 21288773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F(ab')2 antibody fragments against Trypanosoma cruzi calreticulin inhibit its interaction with the first component of human complement.
    Aguilar L; Ramírez G; Valck C; Molina MC; Rojas A; Schwaeble W; Ferreira V; Ferreira A
    Biol Res; 2005; 38(2-3):187-95. PubMed ID: 16238097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C2 receptor inhibitor trispanning confers an increased ability to resist complement-mediated lysis in Trypanosoma cruzi.
    Cestari Idos S; Evans-Osses I; Freitas JC; Inal JM; Ramirez MI
    J Infect Dis; 2008 Nov; 198(9):1276-83. PubMed ID: 18781865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological characterization of Trypanosoma cruzi stocks from Chilean insect vectors.
    Solari A; Wallace A; Ortiz S; Venegas J; Sanchez G
    Exp Parasitol; 1998 Jul; 89(3):312-22. PubMed ID: 9676709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.